PT - JOURNAL ARTICLE AU - Shao-yu Chen AU - Kathleen K. Sulik TI - Iron-Mediated Free Radical Injury in Ethanol-Exposed Mouse Neural Crest Cells DP - 2000 Jul 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 134--140 VI - 294 IP - 1 4099 - http://jpet.aspetjournals.org/content/294/1/134.short 4100 - http://jpet.aspetjournals.org/content/294/1/134.full SO - J Pharmacol Exp Ther2000 Jul 01; 294 AB - Previous studies using cell and whole embryo cultures have shown that free radicals play an important role in the ethanol-induced death of mouse neural crest cells (NCCs; a significant cell type with respect to the genesis of alcohol-related birth defects). This investigation was spurred by reports of increased iron in ethanol-exposed fetuses and the knowledge that iron can initiate the production of reactive oxygen species. Initially, the ameliorative potential of two iron chelators, deferoxamine and phenanthroline, relative to ethanol-induced cell death was examined. Cotreatment of cultured NCCs with 100 mM ethanol and either 1 or 10 μM deferoxamine or 10, 50, or 250 μM phenanthroline significantly increased the percentage of viable cells as compared with exposure to 100 mM ethanol alone. These data indicate that iron is involved in the ethanol-induced cytotoxicity. To support this premise, the direct toxicity of iron to NCCs was also examined. As expected, loading the cells with Fe(II)/Fe(III) using 8-hydroxyquinoline as a carrier had an adverse effect on their viability as did treatment with a neurotoxin, 6-hydroxydopamine, that releases iron from ferritin storage. Cotreatment with an antioxidant,N-acetylcysteine, significantly diminished the toxicity of ethanol alone, that resulting from iron loading, as well as from the combination of ethanol exposure and iron loading. These results confirm the role of free radical-mediated damage in ethanol-induced cytotoxicity and highlight the potential role of iron relative to the genesis of alcohol-related birth defects. The American Society for Pharmacology and Experimental Therapeutics